Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1987 Jul;80(7):428–429. doi: 10.1177/014107688708000711

Association between azathioprine therapy and lymphoma in rheumatoid disease.

P I Pitt 1, A H Sultan 1, M Malone 1, V Andrews 1, E B Hamilton 1
PMCID: PMC1290904  PMID: 3656314

Abstract

Three out of 41 patients treated with azathioprine and low-dose corticosteroids from 1976 to 1983 developed non-Hodgkin's lymphoma. This strikingly high incidence of lymphoma may be a reflection of long-term use of azathioprine.

Full text

PDF
428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes C. G., Turnbull A. L., Vernon-Roberts B. Felty's syndrome. A clinical and pathological survey of 21 patients and their response to treatment. Ann Rheum Dis. 1971 Jul;30(4):359–374. doi: 10.1136/ard.30.4.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hunter T., Urowitz M. B., Gordon D. A., Smythe H. A., Ogryzlo M. A. Azathioprine in rheumatoid arthritis: a long-term follow-up study. Arthritis Rheum. 1975 Jan-Feb;18(1):15–20. doi: 10.1002/art.1780180103. [DOI] [PubMed] [Google Scholar]
  3. Isomäki H. A., Hakulinen T., Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 1978;31(11):691–696. doi: 10.1016/0021-9681(78)90071-1. [DOI] [PubMed] [Google Scholar]
  4. Jack A. S., Boyce B. F., Lee F. D. Malignant histiocytosis complicating rheumatoid arthritis: report of four cases. J Clin Pathol. 1986 Jan;39(1):16–21. doi: 10.1136/jcp.39.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lewis P., Hazleman B. L., Hanka R., Roberts S. Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis. 1980 Oct;39(5):457–461. doi: 10.1136/ard.39.5.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Prior P., Symmons D. P., Hawkins C. F., Scott D. L., Brown R. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis. 1984 Apr;43(2):128–131. doi: 10.1136/ard.43.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Speerstra F., Boerbooms A. M., van de Putte L. B., van Beusekom H. J., Kruijsen M. W., Vandenbroucke J. P. Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience. Ann Rheum Dis. 1982;41 (Suppl 1):37–39. doi: 10.1136/ard.41.suppl_1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Symington G. R., Mackay I. R., Lambert R. P. Cancer and teratogenesis: infrequent occurrence after medical use of immunosuppressive drugs. Aust N Z J Med. 1977 Aug;7(4):368–372. doi: 10.1111/j.1445-5994.1977.tb04397.x. [DOI] [PubMed] [Google Scholar]
  9. Whisnant J. K., Pelkey J. Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. Ann Rheum Dis. 1982;41 (Suppl 1):44–47. doi: 10.1136/ard.41.suppl_1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Zulman J., Jaffe R., Talal N. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med. 1978 Nov 30;299(22):1215–1220. doi: 10.1056/NEJM197811302992204. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES